Suppr超能文献

LKB1/STK11 失活导致黑色素瘤中促转移肿瘤亚群的扩增。

LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

机构信息

Department of Genetics, The Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7295, USA.

出版信息

Cancer Cell. 2012 Jun 12;21(6):751-64. doi: 10.1016/j.ccr.2012.03.048.

Abstract

Germline mutations in LKB1 (STK11) are associated with the Peutz-Jeghers syndrome (PJS), which includes aberrant mucocutaneous pigmentation, and somatic LKB1 mutations occur in 10% of cutaneous melanoma. By somatically inactivating Lkb1 with K-Ras activation (±p53 loss) in murine melanocytes, we observed variably pigmented and highly metastatic melanoma with 100% penetrance. LKB1 deficiency resulted in increased phosphorylation of the SRC family kinase (SFK) YES, increased expression of WNT target genes, and expansion of a CD24(+) cell population, which showed increased metastatic behavior in vitro and in vivo relative to isogenic CD24(-) cells. These results suggest that LKB1 inactivation in the context of RAS activation facilitates metastasis by inducing an SFK-dependent expansion of a prometastatic, CD24(+) tumor subpopulation.

摘要

LKB1(STK11)种系突变与 Peutz-Jeghers 综合征(PJS)相关,其包括黏膜皮肤色素沉着异常,而体细胞 LKB1 突变发生于 10%的皮肤黑色素瘤中。通过在鼠黑素细胞中用 K-Ras 激活(±p53 缺失)来体细胞失活 Lkb1,我们观察到色素沉着可变和高度转移性黑色素瘤,其具有 100%的外显率。LKB1 缺失导致 SRC 家族激酶(SFK)YES 的磷酸化增加,WNT 靶基因的表达增加,以及 CD24(+)细胞群体的扩增,与同基因 CD24(-)细胞相比,其在体外和体内表现出增加的转移行为。这些结果表明,在 RAS 激活的背景下 LKB1 失活通过诱导 SFK 依赖性的促进转移的 CD24(+)肿瘤亚群的扩增来促进转移。

相似文献

3
LKB1 modulates lung cancer differentiation and metastasis.LKB1调节肺癌的分化和转移。
Nature. 2007 Aug 16;448(7155):807-10. doi: 10.1038/nature06030. Epub 2007 Aug 5.

引用本文的文献

6
Immune profiling of premalignant lesions in patients with Peutz-Jeghers syndrome.黑斑息肉综合征患者癌前病变的免疫谱分析。
United European Gastroenterol J. 2025 Apr;13(3):338-348. doi: 10.1002/ueg2.12650. Epub 2024 Aug 22.
9
Role of YES1 signaling in tumor therapy resistance.YES1信号通路在肿瘤治疗耐药中的作用。
Cancer Innov. 2023 Mar 3;2(3):210-218. doi: 10.1002/cai2.51. eCollection 2023 Jun.

本文引用的文献

5
A phase 2 trial of dasatinib in advanced melanoma.达沙替尼治疗晚期黑色素瘤的 2 期临床试验。
Cancer. 2011 May 15;117(10):2202-8. doi: 10.1002/cncr.25766. Epub 2010 Nov 29.
8
Somatic p16(INK4a) loss accelerates melanomagenesis.体细胞 p16(INK4a)缺失可加速黑色素瘤的发生。
Oncogene. 2010 Oct 28;29(43):5809-17. doi: 10.1038/onc.2010.314. Epub 2010 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验